Advances in medical diagnosis, treatment, and care (AMDTC) book series,
Journal Year:
2024,
Volume and Issue:
unknown, P. 85 - 114
Published: Dec. 17, 2024
The
discovery
of
biomarkers
has
revolutionized
the
field
oncology,
providing
critical
insights
into
processes
tumour
initiation
and
progression.
Biomarkers,
which
can
be
genetic,
proteomic,
or
metabolic
in
nature,
serve
as
vital
indicators
for
early
cancer
detection,
prognosis,
personalized
treatment
strategies.
Tumour
undergoes
various
stages
characterized
by
alterations
microenvironment,
angiogenesis,
ultimately
metastasis.
Understanding
these
at
molecular
level
is
crucial
identifying
reliable
biomarkers.
Recent
advances
high-throughput
technologies
such
next-generation
sequencing,
mass
spectrometry,
advanced
imaging
techniques
have
significantly
enhanced
ability
to
discover
validate
new
Despite
promising
advancements,
challenges
remain
translation
biomarker
discoveries
clinical
practice.
This
chapter
provides
a
detailed
current
state
discovery,
highlighting
key
findings
future
directions
this
rapidly
evolving
field.
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: May 16, 2024
Background
Angiogenesis,
the
process
of
forming
new
blood
vessels
from
pre-existing
ones,
plays
a
crucial
role
in
development
and
advancement
cancer.
Although
blocking
angiogenesis
has
shown
success
treating
different
types
solid
tumors,
its
relevance
prostate
adenocarcinoma
(PRAD)
not
been
thoroughly
investigated.
Method
This
study
utilized
WGCNA
method
to
identify
angiogenesis-related
genes
assessed
their
diagnostic
prognostic
value
patients
with
PRAD
through
cluster
analysis.
A
model
was
constructed
using
multiple
machine
learning
techniques,
while
developed
employing
LASSO
algorithm,
underscoring
PRAD.
Further
analysis
identified
MAP7D3
as
most
significant
gene
among
multivariate
Cox
regression
various
algorithms.
The
also
investigated
correlation
between
immune
infiltration
well
drug
sensitivity
Molecular
docking
conducted
assess
binding
affinity
angiogenic
drugs.
Immunohistochemistry
60
tissue
samples
confirmed
expression
MAP7D3.
Result
Overall,
10
key
demonstrated
potential
immune-related
implications
patients.
is
found
be
closely
associated
prognosis
response
immunotherapy.
Through
molecular
studies,
it
revealed
that
exhibits
high
Furthermore,
experimental
data
upregulation
PRAD,
correlating
poorer
prognosis.
Conclusion
Our
important
target
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: Aug. 19, 2024
Background
Cervical
cancer
(CC)
is
the
fourth
most
common
malignancy
among
women
globally
and
serves
as
main
cause
of
cancer-related
deaths
in
developing
countries.
The
early
symptoms
CC
are
often
not
apparent,
with
diagnoses
typically
made
at
advanced
stages,
which
lead
to
poor
clinical
prognoses.
In
recent
years,
numerous
studies
have
shown
that
there
a
close
relationship
between
mast
cells
(MCs)
tumor
development.
However,
research
on
role
MCs
played
still
very
limited
time.
Thus,
study
conducted
single-cell
multi-omics
analysis
human
cells,
aiming
explore
mechanisms
by
interact
microenvironment
CC.
goal
was
provide
scientific
basis
for
prevention,
diagnosis,
treatment
CC,
hope
improving
patients’
prognoses
quality
life.
Method
present
acquired
RNA
sequencing
data
from
ten
samples
ArrayExpress
database.
Slingshot
AUCcell
were
utilized
infer
assess
differentiation
trajectory
cell
plasticity
subpopulations.
Differential
expression
subpopulations
performed,
employing
Gene
Ontology,
gene
set
enrichment
analysis,
variation
analysis.
CellChat
software
package
applied
predict
communication
cells.
Cellular
functional
experiments
validated
functionality
TNFRSF12A
HeLa
Caski
lines.
Additionally,
risk
scoring
model
constructed
evaluate
differences
features,
prognosis,
immune
infiltration,
checkpoint,
across
various
scores.
Copy
number
levels
computed
using
inference
copy
variations.
Result
obtained
93,524
high-quality
classified
into
types,
including
T_NK
endothelial
fibroblasts,
smooth
muscle
epithelial
B
plasma
MCs,
neutrophils,
myeloid
Furthermore,
total
1,392
subdivided
seven
subpopulations:
C0
CTSG+
C1
CALR+
C2
ALOX5+
C3
ANXA2+
C4
MGP+
C5
IL32+
C6
ADGRL4+
MCs.
Notably,
subpopulation
showed
associations
tumor-related
results
indicating
resided
intermediate-to-late
stage
differentiation,
potentially
representing
crucial
transition
point
benign-to-malignant
transformation
CNVscore
bulk
further
confirmed
transforming
state
subpopulation.
revealed
key
receptor
involved
actions
Moreover,
vitro
indicated
downregulating
may
partially
inhibit
development
prognosis
infiltration
based
marker
genes
provided
valuable
guidance
patient
intervention
strategies.
Conclusions
We
first
identified
transformative
tumor-associated
within
critical
impacted
progression
inhibitory
effect
knocking
down
prognostic
ALOX5+MCs
subset
demonstrated
excellent
predictive
value.
These
findings
offer
fresh
perspective
decision-making
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: June 14, 2024
Background
Monocytes
play
a
critical
role
in
tumor
initiation
and
progression,
with
their
impact
on
prostate
adenocarcinoma
(PRAD)
not
yet
fully
understood.
This
study
aimed
to
identify
key
monocyte-related
genes
elucidate
mechanisms
PRAD.
Method
Utilizing
the
TCGA-PRAD
dataset,
immune
cell
infiltration
levels
were
assessed
using
CIBERSORT,
correlation
patient
prognosis
was
analyzed.
The
WGCNA
method
pinpointed
14
crucial
genes.
A
diagnostic
model
focused
monocytes
developed
combination
of
machine
learning
algorithms,
while
prognostic
created
LASSO
algorithm,
both
which
validated.
Random
forest
gradient
boosting
singled
out
CCNA2
as
most
significant
gene
related
monocytes,
its
function
further
investigated
through
enrichment
analysis.
Mendelian
randomization
analysis
association
HLA-DR
high-expressing
Molecular
docking
employed
assess
binding
affinity
targeted
drugs
for
PRAD,
experimental
validation
confirmed
expression
value
Result
Based
identification
by
WGCNA,
we
PRAD
multiple
algorithms.
Additionally,
constructed
demonstrated
excellent
predictive
capabilities.
Analysis
random
algorithms
supported
potential
Gene
revealed
regulation
cycle
cellular
senescence
that
expressing
high
may
promote
results
suggested
strong
targeting
Furthermore,
immunohistochemistry
experiments
validated
upregulation
prognosis.
Conclusion
Our
findings
offer
new
insights
into
monocyte
heterogeneity
holds
novel
drug
Cell Death and Disease,
Journal Year:
2024,
Volume and Issue:
15(7)
Published: July 27, 2024
Abstract
Renal
cell
carcinoma
(RCC)
is
considered
a
“metabolic
disease”
characterized
by
elevated
glycolysis
in
patients
with
advanced
RCC.
Tyrosine
kinase
inhibitor
(TKI)
therapy
currently
an
important
treatment
option
for
RCC,
but
drug
resistance
may
develop
some
patients.
Combining
TKI
targeted
metabolic
provide
more
effective
approach
An
analysis
of
14
RCC
(including
three
needle
biopsy
samples
resistance)
revealed
sing-cell
RNA
sequencing
(scRNA-seq)
that
played
crucial
role
poor
prognosis
and
TCGA-KIRC
gene
set
identified
DEPDC1
as
target
associated
malignant
progression
KIRC.
Subsequent
experiments
demonstrated
promoted
knockdown
could
reverse
lines.
Bulk
(RNA-seq)
non-targeted
metabolomics
suggested
regulate
via
AKT/mTOR/HIF1α
pathway,
finding
supported
protein-level
analysis.
Clinical
tissue
from
98
was
predicted
metastasis.
In
conclusion,
this
multi-omics
suggests
serve
novel
combined
resistance.
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: April 10, 2024
Skin
Cutaneous
Melanoma
(SKCM)
incidence
is
continually
increasing,
with
chemotherapy
and
immunotherapy
being
among
the
most
common
cancer
treatment
modalities.
This
study
aims
to
identify
novel
biomarkers
for
response
in
SKCM
explore
their
association
oxidative
stress.
Frontiers in Pharmacology,
Journal Year:
2025,
Volume and Issue:
16
Published: March 27, 2025
Brain
metastasis
in
breast
cancer
(BCBM)
significantly
threatens
the
survival
and
quality
of
life
patients,
particularly
those
with
triple-negative
(TNBC)
HER2-positive
subtypes.
It
involves
complex
molecular
mechanisms
diverse
signaling
pathways.
This
review
highlights
recent
research
on
pathways
BCBM.
The
process
BCBM
includes
several
key
steps:
local
infiltration
cells
into
bloodstream
subsequent
spread
to
brain.
They
must
then
overcome
blood-brain
barrier
(BBB)
establish
grow
Multiple
pathways,
including
PI3K/AKT,
STAT3,
NF-κB,
Notch,
Wnt
are
involved
this
process.
Overall,
is
a
disease
regulated
by
multiple
To
improve
patient
life,
it
crucial
deepen
explore
new
treatment
targets
strategies.
will
enhance
our
understanding
lead
more
effective
treatments.
Frontiers in Pharmacology,
Journal Year:
2025,
Volume and Issue:
16
Published: Feb. 20, 2025
The
isolation
and
application
of
biological
macromolecules
(BMMs)
have
become
central
in
applied
science
today,
with
these
compounds
serving
as
anticancer,
antimicrobial,
anti-inflammatory
agents.
Parthenolide
(PTL),
a
naturally
occurring
sesquiterpene
lactone
derived
from
Tanacetum
parthenium
(feverfew),
is
among
the
most
important
BMMs.
PTL
has
been
extensively
studied
for
its
anticancer
properties,
making
it
promising
candidate
further
research
drug
development.
This
review
summarizes
effects
derivatives,
focus
on
Micheliolide
(MCL)
Dimethylaminomicheliolide
(DMAMCL).
These
compounds,
PTL,
developed
to
overcome
PTL's
instability
acidic
basic
conditions
low
solubility.
We
also
explore
their
potential
targeted
combination
therapies,
providing
comprehensive
overview
therapeutic
mechanisms
highlighting
significance
future
cancer
treatment
strategies.
Frontiers in Immunology,
Journal Year:
2025,
Volume and Issue:
16
Published: Feb. 28, 2025
Breast
cancer
(BC)
is
the
most
common
in
women
and
a
leading
cause
of
cancer-related
mortality.
Despite
advances
screening
treatment,
outcomes
for
advanced
or
recurrent
BC
remain
poor,
highlighting
need
new
strategies.
Recent
research
emphasizes
tumor
microenvironment
(TME),
particularly
tumor-associated
macrophages
(TAMs),
as
key
drivers
growth,
metastasis,
resistance
to
therapy.
The
presence
M2-like
TAMs
TME
promotes
immune
evasion
progression
across
subtypes.
This
review
summarizes
classification,
their
role
BC,
emerging
therapies
targeting
TAMs,
including
depletion,
inhibition
recruitment,
reprogramming
from
pro-tumoral
M2
anti-tumoral
M1
phenotypes.
Targeting
offers
promising
strategy
improve
treatment
outcomes.
Frontiers in Immunology,
Journal Year:
2025,
Volume and Issue:
16
Published: April 16, 2025
Colorectal
cancer
(CRC)
is
among
the
most
prevalent
and
lethal
cancers
globally,
accounting
for
approximately
10%
of
all
cases
deaths.
Regulatory
T
(Treg)
cells,
which
accumulate
in
CRC
tissue,
suppress
anti-tumor
immune
responses
facilitate
tumor
progression.
This
review
discusses
Treg
cell
origins
functions,
along
with
mechanisms
by
Tregs
influence
development.
In
addition,
we
highlight
therapeutic
strategies
targeting
Tregs-such
as
checkpoint
inhibitors
combinatorial
approaches-to
enhance
effector
responses.
A
deeper
understanding
Treg-mediated
immunosuppression
may
inform
design
more
effective
immunotherapies
precision
medicine
strategies.
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(8), P. 3885 - 3885
Published: April 20, 2025
The
p21-activated
kinases
(PAKs)
are
a
group
of
evolutionarily
conserved
serine/threonine
protein
and
serve
as
downstream
target
the
small
GTPases
Rac
Cdc42,
both
which
belong
to
Rho
family.
PAKs
play
pivotal
roles
in
various
physiological
processes,
including
cytoskeletal
rearrangement
cellular
signal
transduction.
Group
II
(PAK4-6)
particularly
closely
linked
human
tumors,
such
breast
pancreatic
cancers,
while
I
(PAK1-3)
indispensable
for
normal
functions
cardiovascular
development
neurogenesis.
In
recent
years,
association
with
diseases
like
cancer
rise
small-molecule
inhibitors
targeting
have
attracted
significant
attention.
This
article
focuses
on
analysis
PAKs’
role
tumor
progression
immune
infiltration,
well
current
their
mechanisms.